Breastfeeding Roadmap in Primiparous Women
Launched by SELCUK UNIVERSITY · Apr 6, 2025
Trial Information
Current as of July 21, 2025
Recruiting
Keywords
ClinConnect Summary
The clinical trial titled "Breastfeeding Roadmap in Primiparous Women" is designed to help new mothers feel more confident about breastfeeding. Specifically, it will evaluate how a special guide, or "roadmap," can improve mothers' self-belief in their ability to breastfeed successfully. The study has not started recruiting participants yet, but it aims to include women who are about to give birth for the first time (known as primiparous) and are at least 18 years old. To qualify, participants should plan to deliver their baby at 37 weeks or later and must not have any health conditions that would prevent them from breastfeeding or affect their baby’s ability to breastfeed.
If you join this trial, you can expect to receive support and resources aimed at boosting your confidence as a new mother and helping you succeed in breastfeeding. To participate, you should have a basic education level and be willing to volunteer for the study. However, women who have had multiple pregnancies, undergone certain types of surgery, or have specific health issues will not be eligible. This trial is a great opportunity for first-time mothers to gain valuable support during their breastfeeding journey.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Volunteer to participate in the study,
- • Primiparous,
- • Giving birth at 37 weeks of gestation or later,
- • No condition preventing breastfeeding,
- • No condition preventing breastfeeding in the baby,
- • At least primary school graduate,
- • Mothers aged 18 and over
- Exclusion Criteria:
- • Those who have given birth to multiple pregnancies,
- • Those who received general anesthesia for Caesarean section,
- • Those who have any chronic disease, diagnosed mental or psychiatric illness history,
- • Those who have a history of preeclampsia, eclampsia and gestational diabetes,
- • Those whose babies are in intensive care after birth
About Selcuk University
Selçuk University is a prominent educational institution located in Turkey, recognized for its commitment to advancing medical research and clinical studies. As a clinical trial sponsor, Selçuk University leverages its extensive academic resources and expertise to conduct innovative research that aims to address significant healthcare challenges. The university fosters collaboration among researchers, healthcare professionals, and industry partners to facilitate the development of new therapies and improve patient outcomes. Through rigorous adherence to ethical standards and regulatory guidelines, Selçuk University strives to contribute to scientific knowledge and enhance the quality of care within the community and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Konya, , Turkey
Patients applied
Trial Officials
Ebru Bekmezci PhD
Principal Investigator
Selcuk University
Hediye Karakoç PhD
Principal Investigator
KTO Karatay University
Halime Esra Meram PhD
Principal Investigator
Selcuk University
Jule Eriç Horasanlı Doctor, ASSOCIATE PROFESSOR
Principal Investigator
Necmettin Erbakan University Medical Faculty Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported